RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

NEFROLOGÍA. Volumen 24. Suplemento Nº 6 • 2004
Bibliografía
1. Foley RN, Parfrey PS, Sarnak MJ. Cardiovascular disease in
chronic renal disease: Clinical epidemiology of cardiovascular
disease in chronic renal disease. Am J Kidney Dis:32
(Suppl 3):S112-S119, 1998.
2. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after
acute myocardial infarction among patients on long-term
dialysis. N Engl J Med:339:799-805, 1998.
3. Levey AS. Controlling the epidemic of cardiovascular disease
in chronic renal disease: where do we start? Am J Kidney
Dis : 32 (Suppl 3): S5-S13, 1998.
4. Sarnak MJ, Levey AS. Cardiovascular disease and chronic
renal disease: a new paradigm. Am J Kidney Dis: 35 (Suppl
1): S117-S131, 2000.
5. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent
left ventricular hypertrophy in the predialysis population:
identifying opportunities for intervention. Am J Kidney Dis
27: 347-54, 1996.
6. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal
insufficiency as a predictor of cardiovascular outcomes and
the impact of ramipril : the HOPE randomized trial. Ann
Intern Med 134: 629-636; 2001.
7. Ruilope KM, Salvetti A, Jamerson K, Hansson L, Warnold I,
Wedel H y cols. Renal function and intensive lowering of
blood pressure in hypertensive participants of the
Hypertension Optimal Treatment (HOT) study. J Am Soc
Nephrol 12: 218-225; 2001.
8. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B,
Griffith JL y cols. Kidney disease as a risk factor to recurrent
cardiovascular disease and mortality. Am J Kidney Dis 44:
198-206: 2004.
9. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B,
Griffith JL y cols. Kidney disease as a risk factor to recurrent
cardiovascular disease and all-cause mortality: a pooled
analysis of community-based study. J Am Soc Nephrol 15:
1307-15, 2004.
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic
kidney disease and the risk of death, cardiovascular events,
and hospitalization. N Engl J Med 351: 1296-1305, 2004.
11. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD,
Kober L, Rouleau J-L et al. Relation between renal dysfunction
and cardiovascular outcomes after myocardial infarction.
N Engl J Med 351: 1285-1295, 2004.
12. Hostetter TH. Chronic kidney disease predicts cardiovascular
disease. N Engl J Med 351: 1344-1346, 2004.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green
LA Izzo Jr y cols. The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure: the JNC 7 report. JAMA:
289: 2560–2572, 2003.
14. European Society of Hypertension - European Society of
Cardiology guidelines for management of arterial hypertension.
J Hypertens: 21: 1011-1053, 2003.
15. Annual Report: ESRD clinical perfomance measures project.
Am J Kidney Dis: 39 (Suppl 2) S4-S61, 2002.
16. Amenábar JJ, García-López F, Robles NR, Saracho R por el
Comité de Registros de la SEN. Informe de diálisis y trasplante
de la Sociedad Española de Nefrología y Registros
Autonómicos correspondientes al año 1999. Nefrología 21:
246-252, 2001.
17. Palmer BF. Renal dysfunction complicating the treatment of
hypertension. N Engl J Med: 347: 1256-1261, 2002.
18. Burden R, Dasgupta I. How good are nephrogists at controlling
blood pressure in renal patients. Nephrol Dial
Transplant: 15: 440-441, 2000
19. Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA.
Slowing the progression of chronic renal insufficiency.
CAMJ: 166: 906-907, 2002.
20. Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJG,
Steinberg EP. Opportunities for improving the care of
patients with chronic renal insufficiency: current practice
patterns. J Am Soc Nephrol: 12: 1713-1720, 2001.
21. Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Blood pressure
and angiotensin converting enzyme inhibitor use in
hypertensive patients with chronic renal insufficiency. Am J
Hypertens:14:1219-25, 2001.
22. Best PJ, Reddan DN, Berger PB, Szczech LA. McCullough,
Califf RM. Cardiovascular disease and chronic kidney disease:
insights and an update. Am Heart J 148; 230-242, 2004.
23. Nickolas TL, Frisch GD, Opotowsky AR, Arons R,
Radhakrishnan J. Awareness of kidney disease in the US
population: findings from the National Health and Nutrition
Examination Survey (NHANES) 1999 to 2000. Am J Kidney
Dis 44: 185-197, 2004.
24. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B,
Hamm LL y cols. Kidney Disease as a Risk Factor for
Development of Cardiovascular Disease. A Statement From
the American Heart Association Councils on Kidney in
Cardiovascular Disease, High Blood Pressure Research,
Clinical Cardiology, and Epidemiology and Prevention.
Circulation:108:2154-2169, 2003.
25. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, y
cols. National Kidney Foundation Practice Guidelines for
Chronic Kidney Disease: Evaluation, Classification, and
Stratification. Ann Intern Med: 139: 137-147, 2003.
26. K/DOQI Clinical Practice Guidelines for Chronic Kidney
Disease: Evaluation, Classification and Stratification. Am J
Kidney Dis: 39 (Suppl 1): S1-S266, 2002.
27. K/DOQI Clinical Practice Guidelines for managing dyslipidemias
in chronic kidney disease. Am J Kidney Dis: 41
(Suppl 3): S1-S89, 2003.
28. Levey AS, Coresh J. Should the K/DOQI definition of chronic
kidney disease be changed? Am J Kidney Dis: 42:626-630,
2003.
29. K/DOQI clinical practice guidelines on hypertension and
antihypertensive agents in chronic kidney disease. Am J
Kidney Dis 43 (suppl 1): S1-S290, 2004.
30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green
LA Izzo Jr y cols. The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and
187